WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of its innovative technology platform, EffiX™ ...

EffiXTM is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a ...

The startup company MNDL Bio has been named the winner of the Most Innovative Biotech Solution in the Middle East award.

Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

The global mammalian transient protein expression market is on a robust growth trajectory, projected to reach USD 762.34 million in 2024 and expand at a CAGR of 5.5% over the next decade, ultimately ...

Discover the world of therapeutic proteins, their applications, advantages, challenges, and future trends in healthcare and ...

ZUG, SWITZERLAND AND VILNIUS, LITHUANIA / ACCESS Newswire / March 4, 2025 / Micreos Pharmaceuticals AG ("Micreos"), a ...

The microbial fermentation technology market is experiencing significant growth, fueled by the increasing incidence of chronic diseases like cancer a ...

Discover how next-generation kinase inhibitors are transforming clinical therapy byovercoming resistance and enhancing ...

Micreos and Northway Biotech partner to develop scalable cGMP production processes for a biologic therapeutic aimed at ...

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.